GENinCode UK Ltd. (GB:GENI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
GENinCode Plc, a predictive genetics firm targeting cardiovascular and ovarian cancer prevention, has dispatched its 2023 Annual Report and AGM notice to shareholders. The documentation is accessible on the company’s website, with the AGM slated for 27 June 2024 at Cavendish Capital Markets in London. GENinCode continues to expand its innovative risk assessment technology in the UK, Europe, and the US.
For further insights into GB:GENI stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money